IDR-HH2
IDR-HH2 is an immunomodulatory peptide with the ability to modulate the host cytokine/chemokine environment. IDR-HH2 can promote the adhesion of monocytes and THP-1 cells to fibronectin. Additionally, IDR-HH2 possesses antibacterial activity, inhibiting the activity of both P. aeruginosa and S. aureus with MIC values of 75 µg/mL and 38 µg/mL, respectively.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1214699-22-5
- Formule: C62H117N23O13
- Masse moléculaire:1392.74
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Chemical Information
-
CAS No. 1214699-22-5
-
Masse moléculaire 1392.74
-
Formule C62H117N23O13
-
Sequence
Val-Gln-Leu-Arg-Ile-Arg-Val-Ala-Val-Ile-Arg-Ala-NH2
-
Sequence Shortening
VQLRIRVAVIRA-NH2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Madera L, et al. Synthetic immunomodulatory peptide IDR-1002 enhances monocyte migration and adhesion on fibronectin[J]. Journal of innate immunity, 2012, 4(5-6): 553-568. [Content Brief]
[2]. Rivas-Santiago B, et al. Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models[J]. PloS one, 2013, 8(3): e59119. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)